For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful ...

For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful ...

For patients with acute ischemic stroke (AIS) whose symptoms began 4.5 to 24 hours earlier, alteplase is associated w ...

treatment with REC-994 400 mg showed promising signals in both MRI-based lesion volume reduction and functional outcome as ...

Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...

Endovascular thrombectomy (EVT) does not lead to better outcomes at 90 days compared with usual care or best medical treatment for patients with acute ischemic stroke due to medium vessel occlusion.

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...

The following is a summary of “Hyponatremia is associated with malignant brain edema after mechanical thrombectomy in acute ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

MIND was a prospective, open-label trial that enrolled adults up to 80 years old with moderate-large (20-80 mL) ...

Disability was measured by a score of 0-1 on the modified Rankin Scale with ratings from 0 (no disability) to 6 (death). The analysis found: Stroke survivors were 44% more likely to have an ...